BRAINSTORM CELL THERAPEUTICS INC. Long-term Investments
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) had Long-term Investments of $20.00 thousand as of 2015-06-30, per its 10-Q filed 2015-08-13.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:LongTermInvestments · last filed 2015-08-13
- 2015-06-30: Long-term Investments $20.00K.
- 2015-03-31: Long-term Investments $19.00K.
- 2014-12-31: Long-term Investments $20.00K.
- 2014-09-30: Long-term Investments $21.00K.
| Period end | Long-term Investments | Long-term Investments as first filed |
|---|---|---|
| 2015-06-30 | $20.00K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $19.00K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $20.00K 10-Q · filed 2015-08-13 | |
| 2014-09-30 | $21.00K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $15.00K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $13.00K 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $22.00K 10-K · filed 2015-03-26 | |
| 2013-09-30 | $273.00K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $241.00K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $218.00K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $17.00K 10-K · filed 2014-03-27 | $189.00K 10-K · filed 2013-03-14 |
| 2012-09-30 | $163.00K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $151.00K 10-Q/A · filed 2012-08-29 | |
| 2012-03-31 | $146.00K 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $126.00K 10-K · filed 2013-03-14 | |
| 2011-09-30 | $107.00K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $103.00K 10-Q/A · filed 2011-09-07 | |
| 2010-12-31 | $91.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |